Cargando…
Persistent Effects of Intensive Glycemic Control on Retinopathy in Type 2 Diabetes in the Action to Control Cardiovascular Risk in Diabetes (ACCORD) Follow-On Study
OBJECTIVES: This study investigated whether the beneficial effects of intensive glycemic control and fenofibrate treatment of dyslipidemia in reducing retinopathy progression demonstrated in the Action to Control Cardiovascular Risk in Diabetes (ACCORD) Eye Study persisted beyond the clinical trial....
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
American Diabetes Association
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4915557/ https://www.ncbi.nlm.nih.gov/pubmed/27289122 http://dx.doi.org/10.2337/dc16-0024 |
Ejemplares similares
-
Effect of Ranolazine Monotherapy on Glycemic Control in Subjects With Type 2 Diabetes
por: Eckel, Robert H., et al.
Publicado: (2015) -
The TCF7L2 Locus: A Genetic Window Into the Pathogenesis of Type 1 and Type 2 Diabetes
por: Grant, Struan F.A.
Publicado: (2019) -
Closing the Loop on Managing Youth With Type 1 Diabetes: Children Are Not Just Small Adults
por: Sherr, Jennifer L.
Publicado: (2018) -
Ubiquitous Healthcare Service Has the Persistent Benefit on Glycemic Control and Body Weight in Older Adults With Diabetes
por: Kang, Seon Mee, et al.
Publicado: (2012) -
Sotagliflozin, a Dual SGLT1 and SGLT2 Inhibitor, as Adjunct Therapy to Insulin in Type 1 Diabetes
por: Sands, Arthur T., et al.
Publicado: (2015)